Literature DB >> 8192013

MR angiography of the carotid bifurcation: artifacts and limitations.

M R Patel1, R A Klufas, D Kim, R R Edelman, K C Kent.   

Abstract

Although conventional angiography has traditionally been the preoperative study of choice before carotid endarterectomy, alternative noninvasive methods, particularly MR angiography, are being used increasingly for evaluation of the carotid bifurcation [1, 2]. In this essay, we illustrate the limitations of and artifacts associated with two-dimensional (2D) and three-dimensional (3D) time-of-flight (TOF) MR angiography vs conventional angiography when assessing disease of the carotid bifurcation.

Mesh:

Year:  1994        PMID: 8192013     DOI: 10.2214/ajr.162.6.8192013

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Usefulness of coronary MR angiography prior to angioplasty.

Authors:  A J Duerinckx; D Laughrun; B S Lewis
Journal:  Int J Card Imaging       Date:  1999-12

Review 2.  Imaging of carotid artery disease: from luminology to function?

Authors:  J H Gillard
Journal:  Neuroradiology       Date:  2003-09-04       Impact factor: 2.804

3.  A novel method to quantify carotid artery stenosis by Doppler ultrasound: Using the continuity principle.

Authors:  Christopher B Wong; Joseph C Wong
Journal:  Int J Angiol       Date:  2010

4.  Two-dimensional coronary MRA: limitations and artifacts.

Authors:  A J Duerinckx; D P Atkinson; J Mintorovitch; O P Simonetti; M K Vrman
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 5.  MRI of coronary arteries.

Authors:  A J Duerinckx
Journal:  Int J Card Imaging       Date:  1997-06

6.  Highly accelerated time-of-flight magnetic resonance angiography using spiral imaging improves conspicuity of intracranial arterial branches while reducing scan time.

Authors:  Tobias Greve; Nico Sollmann; Andreas Hock; Silke Hey; Velmurugan Gnanaprakasam; Marco Nijenhuis; Claus Zimmer; Jan S Kirschke
Journal:  Eur Radiol       Date:  2019-10-29       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.